欢迎您, 登录 | 注册

首页 | English

X
加载中

During viral infection to host cells, several viruses undergo the process of endocytosis and pH-dependent fusion. By fusion of viral membrane with host cellular membrane, the viral core invades to host cytoplasm. A part of monoclonal antibodies against viral membrane protein have potential to inhibit the viral fusion step. Here we describe in vitro influenza virus-cell fusion inhibition assay. The infected cells expressing viral membrane protein, such as hemagglutinin (HA), on cellular surface are incubated with monoclonal antibodies targeting viral membrane protein. Then the cells are incubated under low pH condition. If the antibody does not inhibit the fusion step, we can see multinucleated giant cells.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Influenza Virus-cell Fusion Inhibition Assay
流感病毒细胞融合抑制试验

免疫学 > 宿主防御 > 综合
作者: Mayo Yasugi
Mayo YasugiAffiliation: Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan
Bio-protocol author page: a1077
 and Kazuyoshi Ikuta
Kazuyoshi IkutaAffiliation: Department of Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
For correspondence: ikuta@biken.osaka-u.ac.jp
Bio-protocol author page: a1076
Vol 3, Iss 24, 12/20/2013, 2499 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1004

[Abstract] During viral infection to host cells, several viruses undergo the process of endocytosis and pH-dependent fusion. By fusion of viral membrane with host cellular membrane, the viral core invades to host cytoplasm. A part of monoclonal antibodies against viral membrane protein have potential to inhibit the viral fusion step. Here we describe in vitro influenza virus-cell fusion inhibition assay. The infected cells expressing viral membrane protein, such as hemagglutinin (HA), on cellular surface are incubated with monoclonal antibodies targeting viral membrane protein. Then the cells are incubated under low pH condition. If the antibody does not inhibit the fusion step, we can see multinucleated giant cells.

Keywords: Endocytosis(endocytosis), PH-dependent fusion(pH依赖的融合), Viral entry(病毒进入), Hemagglutinin(hemagglutinin), Influenza virus(流感病毒)

Materials and Reagents

  1. Monkey kidney cell line CV-1 cells
  2. MDCK-propagated Influenza B viruses (B/Florida/4/2006 and B/Malaysia/2506/2004) provided by the National Institute of Infectious Diseases, Japan
  3. Minimal Essential Medium (MEM) (Sigma-Aldrich, catalog number: M4655)
  4. Fetal Bovine Serum (FBS) (MP Biomedicals, catalog number: 2917054)
  5. Phosphate buffered saline without Ca2+ and Mg2+ (PBS)
  6. Dulbecco’s Modified Eagle’s Medium F12 (DMEMF12) (Life Technologies, catalog number: 11320-033)
  7. Acetylated trypsin (Sigma-Aldrich, catalog number: T6763)
  8. Giemsa stain solution (Wako Pure Chemical Industries, catalog number: 079-04391)
  9. Methanol (Nacalai tesque, catalog number: 21915-93)
  10. Bovine serum albumin (BSA) (Sigma-Aldrich, catalog number: A9576)
  11. Specific pathogen
  12. Monoclonal antibody
  13. MEM powder (Nisshin EM, catalog number: 05901)
  14. HEPES (Sigma-Aldrich, catalog number: H3375)
  15. MES (Wako Pure Chemical Industries, catalog number: 344-08351)
  16. Fusion medium (see Recipes)

Equipment

  1. 96-well cell culture plate (Corning, catalog number: 3596)
  2. CO2 incubator (37 °C, 5% CO2)
  3. Light microscope

Procedure

  1. (Day 1) CV-1 cells in 100 μl MEM including 10% FBS are passaged to 96-well plate at 2.5 x 105/ml and incubated in the CO2 incubator for 24 h.
  2. (Day 2) The cells are rinsed with 100 μl PBS once, adsorbed with 50 μl viruses in MEM at an MOI of 0.3 for 1 h in the CO2 incubator.
  3. The cells are rinsed with 100 μl PBS once, added 100 μl DMEMF12 including 0.2% BSA and incubated for 24 h in the CO2 incubator.
  4. (Day 3) The cells are rinsed with 100 μl MEM twice.
  5. The cells in 100 μl MEM including 2.5 μg/ml acetyrated trypsin are incubated in the CO2 incubator for 15 min.
  6. They are rinsed with 100 μl MEM twice.
  7. 50 μl MEM containing different concentration of monoclonal antibody (concentration is 100, 25, 6.25, 1.5, 0.4 and 0.1 μg/ml) is incubated with the cells in different wells for 30 min in the CO2 incubator.
  8. After aspiration of medium, 100 μl fusion medium with each of pH is added and then incubated for 2 min in the CO2 incubator.
  9. The cells are rinsed with 100 μl MEM twice.
  10. The cells are suspended with 100 μl DMEMF12 including 0.2% BSA and incubated in the CO2 incubator for 3 h.
  11. After aspiration of medium, the cells are fixed using 100 μl absolute methanol for 30 sec.
  12. After aspiration of methanol, the cells are stained with 100 μl diluted Giemsa staining solution (1 drop per ml dH2O) for 30 min at room temperature.
  13. After rinsing the cells on tap water, the cells are observed by microscope (Figure 1).


    Figure 1. Giemsa staining of CV-1 cells in fusion inhibition assay. Arrow heads show multinuclear giant cells.

Recipes

  1. Fusion medium
    Mix 2x MEM with 10 mM MES and 10 mM HEPES
    Adjust to pH 5.0, 5.5, 6.0, 6.5 and 7.0
    Mess up to 1x MEM
    Autoclaved

Acknowledgments

This work was supported in part by the Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/JICA, SATREPS) (http://www.jst.go.jp/global/kadai/h2011_thailand.html); and a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science to MY (#23790660).

References

  1. Yasugi, M., Kubota-Koketsu, R., Yamashita, A., Kawashita, N., Du, A., Sasaki, T., Nishimura, M., Misaki, R., Kuhara, M., Boonsathorn, N., Fujiyama, K., Okuno, Y., Nakaya, T. and Ikuta, K. (2013). Human monoclonal antibodies broadly neutralizing against influenza B virus. PLoS Pathog 9(2): e1003150.


How to cite this protocol: Yasugi, M. and Ikuta, K. (2013). Influenza Virus-cell Fusion Inhibition Assay. Bio-protocol 3(24): e1004. DOI: 10.21769/BioProtoc.1004; Full Text



可重复性反馈:

  • 添加图片
  • 添加视频

我们的目标是让重复别人的实验变得更轻松,如果您已经使用过本实验方案,欢迎您做出评价。我们鼓励上传实验图片或视频与小伙伴们(同行)分享您的实验心得和经验。(评论前请登录)

问题&解答:

  • 添加图片
  • 添加视频

(提问前,请先登陆)bio-protocol作为媒介平台,会将您的问题转发给作者,并将作者的回复发送至您的邮箱(在bio-protocol注册时所用的邮箱)。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片或者视频的形式来说明遇到的问题。由于本平台用Youtube储存、播放视频,作者需要google 账户来上传视频。


登陆 | 注册
分享
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook
Mayo Yasugi的其他实验方案(1)